Miia Bovellan is a Founding Partner at Proxy Ventures, a London-based venture capital and design studio where she. See sector focus and contact routes.
Miia Bovellan is a Founding Partner at Proxy Ventures, a London-based venture capital and design studio where she co-founded the firm after transitioning from a research career in life sciences[1][3]. She holds a PhD in life sciences from University College London and previously worked as a PhD researcher specializing in cellular and molecular biology[1][2]. Proxy Ventures invests in startups across the Nordics, Europe, the UK, and the US, with Bovellan focusing on research, strategy, and advising startups on pitch decks to secure funding[2][3]. Her portfolio includes notable companies such as Supercell, Oura, and Argent, which she helped create as part of the firm’s brand-building efforts[3]. Bovellan serves as a Board Member for ASK Scandinavia and Oxidane Venture AS, and holds the role of Chief Science Officer at TrueMed[3]. While specific check sizes and lead/follow behavior are not publicly detailed, her distinctive point of view centers on helping startups structure compelling pitch narratives and aligning with investors who share their goals and values[2][9]. She is also a Pledger with Founders Pledge, committing to philanthropy through entrepreneurial success[3].
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in London.
Investors like Miia Bovellan · Full investor directory · Investor access · Company funding database